PHIO PHARMACEUTICALS CORP.

PHIO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K Jul 30, 2025 FORM 8-K
ARS Jul 30, 2025 FORM ARS
DEFA14A Jul 30, 2025 ADDITIONAL DEFINITIVE PROXY MATERIALS
DEF 14A Jul 30, 2025 DEFINITIVE PROXY
8-K Jul 25, 2025 CURRENT REPORT
8-K Jul 7, 2025 CURRENT REPORT
8-K Jun 26, 2025 CURRENT REPORT
3 Jun 18, 2025 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
8-K Jun 12, 2025 FORM 8-K
4 Jun 11, 2025 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Jun 11, 2025 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Jun 10, 2025 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 May 23, 2025 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 May 21, 2025 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
10-Q May 15, 2025 FORM 10-Q
8-K May 15, 2025 CURRENT REPORT
8-K May 7, 2025 FORM 8-K
8-K Apr 22, 2025 FORM 8-K
8-K Apr 9, 2025 CURRENT REPORT
10-K Mar 31, 2025 FORM 10-K FOR DEC 2024
8-K Mar 31, 2025 CURRENT REPORT
3 Mar 4, 2025 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
8-K Feb 20, 2025 FORM 8-K
SCHEDULE 13G/A Feb 7, 2025
424B3 Jan 29, 2025 PROSPECTUS
← Newer Page 4 of 36 · 883 filings Older →